Log in

TLRY Tilray Brands, Inc. NASDAQ · United States

Tilray Brands (TLRY) news

Tilray Brands, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TLRY, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Tilray Brands news

We have not published a story on Tilray Brands yet. When there is news, it will appear here.

What Tilray Brands does

Tilray Brands is a global lifestyle consumer products company operating at the nexus of cannabis, beverage, wellness and entertainment. Its portfolio includes beer and beverage brands such as SweetWater Brewing, Montauk Brewing, BrewDog, Shock Top, 10 Barrell, Breckenridge Brewery and Blue Point Brewing, along with cannabis and wellness brands such as Manitoba Harvest. The company says it is the 4th largest craft brewer in the U.S. and that it leads the Canadian cannabis market with the highest cannabis revenue in Canada. Its Manitoba Harvest business is a leader in the hemp-based food category in the U.S. Outside North America, the company says it has provided medical cannabis products to patients in over 20 countries spanning five continents through its global subsidiaries and distributors. In its fiscal year ended May 31, 2026, it acquired BrewDog, which the text describes as the only global craft beer brand. Its strategy centers on brands, data analytics and consumer insights, cost management and new categories and geographies.

Product or programWhat it isStage
BrewDogGlobal craft beer brand acquired in fiscal 2026
Manitoba HarvestHemp-based food business, a leader in the U.S. hemp-based food category
medical cannabis productsMedical cannabis products supplied to patients in over 20 countries

Summarised from the company's 10-K filed Jul 28, 2026.

Tilray Brands annual financials

LineFY ended May 31, 2026FY ended May 31, 2025
Revenue$915.5 million$821.3 million
Research and development$361,000$284,000
Net income (loss)-$121.4 million-$2.19 billion
Cash from operations-$69.1 million-$94.6 million
Cash and equivalents$226.0 million$221.7 million
Short-term investments$5.3 million$34.7 million

Latest balance sheet, Aug 31, 2026 (10-Q): cash and equivalents $215.0 million, plus short-term investments of $3.0 million, $218.0 million in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Tilray Brands

What is the ticker symbol of Tilray Brands?

Tilray Brands, Inc. trades under the ticker TLRY on NASDAQ.

Where is Tilray Brands listed?

Tilray Brands, Inc. is listed on NASDAQ.

Which country or territory is Tilray Brands listed under?

Our directory records Tilray Brands, Inc. under United States.

Does aibio.space cover Tilray Brands?

aibio.space lists Tilray Brands, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What does Tilray Brands develop?

Tilray Brands is a global lifestyle consumer products company operating at the nexus of cannabis, beverage, wellness and entertainment. Its portfolio includes beer and beverage brands such as SweetWater Brewing, Montauk Brewing, BrewDog, Shock Top, 10 Barrell, Breckenridge Brewery and Blue Point Brewing, along with cannabis and wellness brands such as Manitoba Harvest.

What is BrewDog from Tilray Brands?

BrewDog: Global craft beer brand acquired in fiscal 2026

What is Manitoba Harvest from Tilray Brands?

Manitoba Harvest: Hemp-based food business, a leader in the U.S. hemp-based food category

What was Tilray Brands's revenue last year?

$915.5 million for the fiscal year ended May 31, 2026, as reported to the SEC.

Is Tilray Brands profitable?

Tilray Brands, Inc. reported a net loss of $121.4 million for the fiscal year ended May 31, 2026, and used $69.1 million of cash in operations, per its annual report to the SEC.

How much does Tilray Brands spend on research and development?

$361,000 in the fiscal year ended May 31, 2026, per its annual report.

How much cash does Tilray Brands have?

$218.0 million in cash and short-term investments at Aug 31, 2026, per its 10-Q.

Investor discussion: Tilray Brands

Members talk about Tilray Brands (TLRY). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:TLRY on TradingView.

Listing details

Tilray Brands, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TLRY, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Tilray Brands, Inc.
Ticker
TLRY
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.